Breaking Barriers in Breast Cancer: Multi-Targeted Therapeutic Insights

The future of breast cancer therapy lies in combination strategies that are developed via molecular profiling and guided by resistance biomarkers. Integrative, biomarker-driven treatment approaches will provide a rationalized and likely more effective means of treating advanced and refractory breast cancer in our effort to improve patient outcomes in a targeted and personalized approach.